Future challenges for the economic evaluation of healthcare: Patient preferences, risk attitudes and beyond

PharmacoEconomics

Volumn 23, Issue 4, 2005, Pages 317-321

  Bridges, John F P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUING EDUCATION; ECONOMIC EVALUATION; HEALTH ECONOMICS; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; RISK;

ATTITUDE; DELIVERY OF HEALTH CARE; HUMANS; PATIENT SATISFACTION; RISK; RISK ASSESSMENT;

EID: 18744381010     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200523040-00002     Document Type: Review

References (18)

1. Briggs A, Wonderling D, Mooney C. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997; 6: 327-40
2. Graff Zivin J. Cost-effectiveness analysis with risk aversion. Health Econ 2001; 10: 499-508
3. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999; 18: 341-64
4. Meltzer D. Addressing uncertainty in medical cost-effectiveness analysis: implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research. J Health Econ 2001; 20: 109-29
5. Sendi P, Gafni A, Birch S. Opportunity costs and uncertainty in the economic evaluation of health care interventions. Health Econ 2002; 11 (1): 23-31
6. Birch S, Gafni A. Cost effectiveness/utility analysis: do current decision rules lead us to where we want to be? J Health Econ 1992; 11 (3): 279-96
7. Birch S, Gafni A. Cost effectiveness ratios: in a league of there own. Health Policy 1994; 28: 133-41
8. Bridges J. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy 2003; 2 (4): 213-24
9. Graff Zivin J, Bridges J. Addressing risk preferences in cost-effectiveness analyses. Appl Health Econ Health Policy 2002; 1 (3): 135-9
10. Bridges J. Understanding the risks associated with resource allocation decisions in health: an illustration of the importance of portfolio theory. Health, Risk and Society 2004; 6 (3): 257-75
11. Donaldson C, Shackley P. Does 'process utility' exist? A case study of willingness to pay for laparoscopic cholesystectomy. Soc Sci Med 1997; 44 (5): 699-707
12. Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003; 2 (1): 55-64
13. Maynard A, Sheldon T. (1997) Health economics: has it fulfilled its potential? In: Maynard A, Charmers I, editors. Non-random reflections on health services research. London: BMA Publications and Nuffield Provincial Trust, 1997: 149-65
14. Birch S, Donaldson C. Valuing the benefits and costs of health care programmes: where's the extra in extra wefarism? Soc Sci Med 2003; 56: 1121-33
15. Roter D. Patient-centered communication. BMJ 2004 Jun 12; 328 (7453): E303-4
16. Bridges J, Terris D. Portfolio evaluation of health programs: a reply to Sendi, et al. Soc Sci Med 2004; 58: 1849-51
17. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilization. Soc Sci Med 1999; 48: 535-46
18. Bowles S. Endogenous preferences: the culture consequences of markets and other economic institutions. J Econ Lit 1998; 36 (1): 75-111